# SODIUM PHENYLACETATE AND SODIUM BENZOATE
> **ANDA207096** · Abbreviated New Drug Application (Generic) · Sponsor: AILEX PHARMS LLC · Approved 2016-02-24
## Drug
- **FDA Application Number:** ANDA207096
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SODIUM PHENYLACETATE AND SODIUM BENZOATE
- **Generic name:** SODIUM PHENYLACETATE AND SODIUM BENZOATE
- **Active ingredients:** SODIUM BENZOATE; SODIUM PHENYLACETATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** AILEX PHARMS LLC
- **Manufacturer:** Omnivium Pharmaceuticals LLC
- **First approval:** 2016-02-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207096)
---
*MORVS · CC0 1.0*